| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Neoplasms | 13 | 2021 | 529 | 3.320 |
Why?
|
| CRISPR-Cas Systems | 9 | 2024 | 323 | 2.340 |
Why?
|
| Gene Editing | 8 | 2024 | 216 | 2.220 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 8 | 2021 | 328 | 1.940 |
Why?
|
| Teratoma | 4 | 2021 | 236 | 1.550 |
Why?
|
| Embryonic Germ Cells | 3 | 2021 | 9 | 1.410 |
Why?
|
| Embryonal Carcinoma Stem Cells | 3 | 2021 | 13 | 0.930 |
Why?
|
| Cell Differentiation | 5 | 2021 | 4078 | 0.910 |
Why?
|
| Sex Differentiation | 1 | 2021 | 41 | 0.790 |
Why?
|
| Mice | 44 | 2024 | 34495 | 0.770 |
Why?
|
| Mice, Knockout | 16 | 2023 | 5710 | 0.690 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 106 | 0.630 |
Why?
|
| Intestinal Polyposis | 2 | 2015 | 30 | 0.630 |
Why?
|
| Germ Cells | 4 | 2023 | 335 | 0.630 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 132 | 0.620 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 45 | 0.550 |
Why?
|
| Cyclin D1 | 2 | 2016 | 576 | 0.550 |
Why?
|
| Animals | 47 | 2024 | 59536 | 0.550 |
Why?
|
| Genes, Lethal | 2 | 2022 | 120 | 0.540 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 5539 | 0.530 |
Why?
|
| Embryo, Mammalian | 4 | 2022 | 741 | 0.520 |
Why?
|
| Testis | 2 | 2017 | 717 | 0.500 |
Why?
|
| Genetic Association Studies | 5 | 2021 | 1084 | 0.480 |
Why?
|
| Ovary | 1 | 2017 | 668 | 0.440 |
Why?
|
| Interleukins | 1 | 2015 | 325 | 0.440 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 123 | 0.390 |
Why?
|
| Genome | 4 | 2023 | 672 | 0.360 |
Why?
|
| Osteoporosis | 2 | 2021 | 241 | 0.330 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 92 | 0.330 |
Why?
|
| Integrases | 3 | 2023 | 262 | 0.320 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 87 | 0.320 |
Why?
|
| Intellectual Disability | 3 | 2021 | 1032 | 0.320 |
Why?
|
| Mice, 129 Strain | 3 | 2018 | 170 | 0.320 |
Why?
|
| Transgenes | 2 | 2006 | 557 | 0.300 |
Why?
|
| Alleles | 6 | 2023 | 2437 | 0.300 |
Why?
|
| Chromosomes, Artificial | 1 | 2006 | 1 | 0.290 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 1390 | 0.290 |
Why?
|
| Mice, Transgenic | 7 | 2023 | 4143 | 0.280 |
Why?
|
| Gene Deletion | 5 | 2021 | 1442 | 0.280 |
Why?
|
| Cell Proliferation | 5 | 2022 | 7226 | 0.250 |
Why?
|
| Phenotype | 9 | 2023 | 6295 | 0.250 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2004 | 30 | 0.250 |
Why?
|
| Forkhead Transcription Factors | 2 | 2021 | 778 | 0.250 |
Why?
|
| Oocytes | 2 | 2024 | 414 | 0.250 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 24 | 0.250 |
Why?
|
| Zygote | 1 | 2024 | 36 | 0.250 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2004 | 129 | 0.240 |
Why?
|
| Stem Cells | 3 | 2006 | 1213 | 0.240 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 984 | 0.230 |
Why?
|
| Mutation | 11 | 2024 | 15179 | 0.230 |
Why?
|
| Mice, Inbred Strains | 3 | 2023 | 521 | 0.230 |
Why?
|
| Capsid | 1 | 2023 | 103 | 0.230 |
Why?
|
| Ciliopathies | 1 | 2022 | 12 | 0.220 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2023 | 69 | 0.220 |
Why?
|
| Coloboma | 1 | 2023 | 43 | 0.220 |
Why?
|
| Anophthalmos | 1 | 2023 | 23 | 0.220 |
Why?
|
| Gene Targeting | 1 | 2004 | 292 | 0.220 |
Why?
|
| Microphthalmos | 1 | 2023 | 57 | 0.220 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2021 | 92 | 0.220 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 286 | 0.220 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 406 | 0.220 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 16 | 0.210 |
Why?
|
| Eye Abnormalities | 1 | 2023 | 118 | 0.210 |
Why?
|
| Pyroptosis | 1 | 2022 | 22 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 238 | 0.210 |
Why?
|
| Male | 21 | 2024 | 123000 | 0.210 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 19 | 0.200 |
Why?
|
| Semaphorins | 1 | 2021 | 38 | 0.200 |
Why?
|
| Exons | 3 | 2023 | 1328 | 0.200 |
Why?
|
| Coatomer Protein | 1 | 2021 | 35 | 0.200 |
Why?
|
| Epithelial Cells | 2 | 2022 | 1818 | 0.200 |
Why?
|
| Aniridia | 1 | 2021 | 17 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 1217 | 0.200 |
Why?
|
| Neoplasm Proteins | 4 | 2024 | 3230 | 0.200 |
Why?
|
| Cells | 1 | 2021 | 31 | 0.200 |
Why?
|
| Endometriosis | 1 | 2024 | 214 | 0.200 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4638 | 0.190 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 49 | 0.190 |
Why?
|
| Bone and Bones | 2 | 2021 | 619 | 0.190 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 208 | 0.190 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 72 | 0.190 |
Why?
|
| Genotype | 5 | 2021 | 4109 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 630 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 8873 | 0.180 |
Why?
|
| Osteoclasts | 1 | 2020 | 165 | 0.180 |
Why?
|
| Introns | 1 | 2021 | 432 | 0.180 |
Why?
|
| Spermatogonia | 1 | 2021 | 155 | 0.180 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 3578 | 0.180 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 105 | 0.180 |
Why?
|
| Disease Models, Animal | 7 | 2023 | 7222 | 0.170 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 18 | 0.170 |
Why?
|
| Population Health | 1 | 2020 | 51 | 0.170 |
Why?
|
| Flow Cytometry | 2 | 2018 | 3033 | 0.170 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 77 | 0.160 |
Why?
|
| Osteoblasts | 1 | 2020 | 370 | 0.160 |
Why?
|
| Sex Determination Processes | 1 | 2018 | 17 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 6 | 2023 | 6942 | 0.160 |
Why?
|
| Disease | 1 | 2020 | 165 | 0.160 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 82 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 1498 | 0.160 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 233 | 0.160 |
Why?
|
| Bone Density | 1 | 2020 | 476 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2008 | 2819 | 0.150 |
Why?
|
| Female | 19 | 2024 | 141928 | 0.150 |
Why?
|
| Genomics | 2 | 2020 | 2738 | 0.150 |
Why?
|
| Gene Dosage | 3 | 2017 | 829 | 0.150 |
Why?
|
| Electrocardiography | 1 | 2023 | 1145 | 0.150 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 83 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 363 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2021 | 11965 | 0.150 |
Why?
|
| Complement C5a | 1 | 2016 | 36 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 674 | 0.140 |
Why?
|
| Leydig Cells | 1 | 2016 | 39 | 0.140 |
Why?
|
| Sequence Deletion | 2 | 2017 | 875 | 0.140 |
Why?
|
| Transcription Factors | 3 | 2023 | 5270 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2017 | 220 | 0.130 |
Why?
|
| Interleukin-33 | 1 | 2015 | 23 | 0.130 |
Why?
|
| Gene Expression | 3 | 2017 | 3570 | 0.130 |
Why?
|
| Sertoli Cells | 1 | 2016 | 150 | 0.130 |
Why?
|
| Meiosis | 1 | 2016 | 166 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 598 | 0.130 |
Why?
|
| Mutagenesis | 3 | 2023 | 483 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 1533 | 0.130 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 241 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 467 | 0.120 |
Why?
|
| Gene Knockout Techniques | 3 | 2022 | 276 | 0.120 |
Why?
|
| Wound Healing | 2 | 2022 | 815 | 0.120 |
Why?
|
| Transcriptome | 3 | 2022 | 1859 | 0.120 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 189 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 7548 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2015 | 133 | 0.120 |
Why?
|
| Th2 Cells | 1 | 2015 | 257 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 4053 | 0.120 |
Why?
|
| Homozygote | 2 | 2022 | 717 | 0.120 |
Why?
|
| Mast Cells | 1 | 2015 | 223 | 0.120 |
Why?
|
| Mitosis | 1 | 2016 | 615 | 0.110 |
Why?
|
| Proteins | 3 | 2023 | 1963 | 0.110 |
Why?
|
| Lung | 2 | 2021 | 3151 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 613 | 0.110 |
Why?
|
| Colonic Polyps | 1 | 2015 | 209 | 0.110 |
Why?
|
| Software | 1 | 2020 | 1321 | 0.110 |
Why?
|
| Genome, Human | 1 | 2021 | 1869 | 0.110 |
Why?
|
| Cytidine Deaminase | 1 | 2012 | 83 | 0.110 |
Why?
|
| Histological Techniques | 1 | 2012 | 65 | 0.110 |
Why?
|
| Capsid Proteins | 2 | 2023 | 185 | 0.110 |
Why?
|
| Nanog Homeobox Protein | 1 | 2012 | 65 | 0.110 |
Why?
|
| Inheritance Patterns | 2 | 2012 | 139 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2019 | 1549 | 0.100 |
Why?
|
| Base Sequence | 4 | 2022 | 4917 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2023 | 1439 | 0.100 |
Why?
|
| Humans | 24 | 2024 | 261506 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 598 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 2146 | 0.100 |
Why?
|
| DNA Damage | 1 | 2019 | 1954 | 0.100 |
Why?
|
| Species Specificity | 1 | 2012 | 777 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 998 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2019 | 2086 | 0.090 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 21 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2012 | 568 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 4549 | 0.090 |
Why?
|
| Obesity | 2 | 2016 | 2884 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 2508 | 0.080 |
Why?
|
| Animals, Congenic | 1 | 2008 | 7 | 0.080 |
Why?
|
| Solubility | 1 | 2008 | 242 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 1547 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 241 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2023 | 1694 | 0.080 |
Why?
|
| Zebrafish | 2 | 2021 | 463 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2013 | 6150 | 0.080 |
Why?
|
| Triglycerides | 1 | 2010 | 603 | 0.070 |
Why?
|
| Cytokines | 1 | 2016 | 2809 | 0.070 |
Why?
|
| Epistasis, Genetic | 1 | 2007 | 119 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2010 | 448 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 62 | 0.070 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 602 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 1143 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2008 | 512 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 374 | 0.070 |
Why?
|
| Biometry | 1 | 2008 | 241 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 324 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2008 | 842 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 201 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 218 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2007 | 339 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2006 | 271 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2004 | 87 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2021 | 5637 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2010 | 731 | 0.060 |
Why?
|
| Genetic Therapy | 2 | 2022 | 1616 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 837 | 0.060 |
Why?
|
| X Chromosome | 1 | 2004 | 339 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2021 | 1682 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2021 | 16273 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 4821 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 6089 | 0.060 |
Why?
|
| Pregnancy | 2 | 2022 | 7573 | 0.050 |
Why?
|
| Dependovirus | 1 | 2023 | 135 | 0.050 |
Why?
|
| Age Factors | 1 | 2012 | 5377 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 158 | 0.050 |
Why?
|
| Cilia | 1 | 2022 | 92 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 356 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2022 | 159 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2004 | 435 | 0.050 |
Why?
|
| Progesterone | 1 | 2024 | 513 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2359 | 0.050 |
Why?
|
| Bivalvia | 1 | 2001 | 10 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 6009 | 0.050 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 29 | 0.050 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 47 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 361 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 161 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 131 | 0.050 |
Why?
|
| Eye | 1 | 2023 | 301 | 0.050 |
Why?
|
| Facies | 1 | 2021 | 149 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2020 | 80 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 436 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 147 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 234 | 0.050 |
Why?
|
| Apoptosis | 1 | 2015 | 7591 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2021 | 204 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2023 | 306 | 0.050 |
Why?
|
| Prevalence | 1 | 2008 | 3260 | 0.050 |
Why?
|
| Endometrium | 1 | 2024 | 470 | 0.050 |
Why?
|
| Genes, Essential | 1 | 2020 | 48 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 149 | 0.040 |
Why?
|
| Estrogens | 1 | 2024 | 751 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 141 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 308 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 294 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 185 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 323 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 1443 | 0.040 |
Why?
|
| Binding Sites | 2 | 2017 | 2171 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 338 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 3101 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2022 | 1008 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 267 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 105 | 0.040 |
Why?
|
| Genes | 1 | 2020 | 491 | 0.040 |
Why?
|
| Methotrexate | 1 | 2022 | 999 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 1077 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 212 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 1392 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2022 | 850 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 272 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 417 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 1489 | 0.040 |
Why?
|
| Amino Acids | 1 | 2020 | 728 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2022 | 1459 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1064 | 0.040 |
Why?
|
| Cell Line | 1 | 2004 | 5114 | 0.030 |
Why?
|
| Internet | 1 | 2021 | 706 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 2016 | 202 | 0.030 |
Why?
|
| Complement Activation | 1 | 2016 | 94 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 2218 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2022 | 2450 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 2216 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 2283 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 1491 | 0.030 |
Why?
|
| DNA Primers | 2 | 2007 | 1399 | 0.030 |
Why?
|
| Cell Movement | 1 | 2022 | 2466 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 589 | 0.030 |
Why?
|
| Child | 3 | 2021 | 29154 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 2045 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2022 | 4804 | 0.030 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2012 | 10 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 1890 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 3203 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 750 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 2265 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 6100 | 0.030 |
Why?
|
| Lewis X Antigen | 1 | 2011 | 46 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 1154 | 0.030 |
Why?
|
| Seizures | 1 | 2017 | 989 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2011 | 107 | 0.020 |
Why?
|
| Epigenomics | 1 | 2012 | 266 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 4320 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 3438 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 1020 | 0.020 |
Why?
|
| RNA Splicing Factors | 1 | 2010 | 153 | 0.020 |
Why?
|
| Lipolysis | 1 | 2010 | 108 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 99 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 1323 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 3343 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 1163 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 5159 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2010 | 229 | 0.020 |
Why?
|
| Muscles | 1 | 2010 | 416 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 597 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 3552 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8223 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 4113 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 31252 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 584 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 2139 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2007 | 56 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 703 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 313 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 1099 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 7702 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1516 | 0.020 |
Why?
|
| United States | 1 | 2021 | 15433 | 0.010 |
Why?
|
| Glucose | 1 | 2010 | 1248 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 1293 | 0.010 |
Why?
|
| Hemocytes | 1 | 2001 | 10 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2001 | 76 | 0.010 |
Why?
|
| Tumor Protein p73 | 1 | 2001 | 105 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 5112 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 21445 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 2961 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 997 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 826 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 834 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 4233 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 1823 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 77950 | 0.010 |
Why?
|
| Leukemia | 1 | 2001 | 1635 | 0.010 |
Why?
|